BIBLIOGRAPHIC RECORD

NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Andrew Alan Nierenberg; Philip T. Lavin; Daniel C. Javitt; Richard C. Shelton; Michael T. Sapko; Sanjay J. Mathew; Robert E. Besthof; Jonathan C. Javitt
Source of metadata
OpenAlex
Year recorded
2023

Public identifiers and source

Open the source record

Reference

Andrew Alan Nierenberg; Philip T. Lavin; Daniel C. Javitt; Richard C. Shelton; Michael T. Sapko; Sanjay J. Mathew; Robert E. Besthof; Jonathan C. Javitt. (2023). NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial. https://openalex.org/W4385787511

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-9c3cedf878d0955d901f4e058f474569/